How to Track Symptoms Between Low-Dose Ketamine Treatments

Track symptoms between low-dose ketamine treatments by rating your mood, anxiety, pain, sleep, and side effects on the same 0-10 scale at the same time of day, then bringing that log to your prescriber before each follow-up. Consistent tracking is how you and your clinician find out whether a low-dose (subanesthetic) ketamine protocol is actually working, since the antidepressant and pain-relieving effects reported in clinical studies can fade unevenly across the days between doses, and single-session memories are unreliable for spotting that pattern. This guide covers what to track, which tools clinicians commonly rely on, and how to turn your notes into a useful conversation about dosing and spacing rather than a guess you make on your own.

Why Symptom Tracking Between Sessions Matters

Low-dose ketamine is prescribed off-label for depression and chronic pain. Only esketamine, a chemical relative of ketamine delivered as a nasal spray under the brand name Spravato, holds Food and Drug Administration (FDA) approval, and that approval is specifically for treatment-resistant depression used alongside an oral antidepressant. Because most low-dose ketamine protocols fall outside that approved use, the published evidence on exactly how long a benefit lasts between treatments is thinner than it is for many standard psychiatric medications, and response patterns vary considerably from person to person.

Research summarized by the National Institute of Mental Health (NIMH) describes ketamine's antidepressant effect as capable of appearing within hours, but it often weakens over the following days to weeks, part of why maintenance protocols use repeated, spaced dosing instead of a single treatment. A written log is more reliable than memory for catching that decline, because people tend to over-remember the best day after a session and under-remember the gradual return of symptoms in between. Tracking also gives your prescriber objective information for deciding how far apart your low-dose ketamine treatments should be spaced and whether your current ketamine depression dose is still doing its job.

What to Track Between Treatments

Mood and anxiety

Depression and anxiety scores are the core of most tracking plans for people using low-dose ketamine as part of a depression protocol. A daily 0-10 mood rating, paired with a weekly PHQ-9 or GAD-7, lets you and your prescriber see both the day-to-day trend and a clinically standardized checkpoint. Many clinics already build this into PHQ-9 and GAD-7 ketamine dose adjustment decisions, so keeping your own copy of these scores between visits saves time and reduces reliance on memory during a short appointment.

Pain, if you're being treated for chronic pain

If ketamine is part of a chronic pain protocol, track pain intensity, the areas affected, and how pain interferes with daily activities such as sleep, work, or mobility. Note whether relief tracks the ketamine low dose ketamine therapy schedule or seems unrelated, since that distinction affects how your prescriber interprets the treatment's contribution.

Sleep and energy

Sleep disruption and fatigue often move together with mood and pain, and can also be side effects of ketamine itself. Recording hours slept and a simple quality rating helps separate a treatment effect from an unrelated sleep problem.

Side effects and safety signals

Note any dissociation, headache, nausea, elevated blood pressure if you check it, urinary symptoms, or cognitive fog that lasts beyond the day of treatment. Most acute ketamine side effects resolve within hours, so a pattern that persists or worsens over successive sessions is worth flagging. See how ketamine side effects typically resolve for a baseline timeline to compare against.

Tools You Can Use

You don't need a specialized app to track symptoms usefully. A paper notebook, a spreadsheet with one row per day, or a notes app with a repeating daily reminder all work as long as you use the same format every time. Some people prefer a symptom-tracking app that exports a PDF summary, which can save time at appointments.

What matters more than the tool is consistency: the same scale, the same items, and a note of where each entry falls relative to your last treatment. Researchers are also studying biological markers, such as inflammatory and neuroplasticity signals, that might one day help predict or confirm ketamine response, but that work remains investigational and is not yet part of routine biomarkers of ketamine response monitoring. For now, self-reported symptom scales remain the practical standard.

Turning Your Log Into a Conversation With Your Prescriber

Your prescriber uses your log to evaluate two related questions: whether the current dose is producing enough benefit, and whether the interval between sessions is too long, too short, or about right. If your tracking consistently shows symptoms returning several days before your next scheduled session, that pattern is useful evidence for a conversation about spacing or about whether ketamine tolerance may be reducing how long each dose's effect lasts.

It also helps to know what the broader evidence shows about durability and dropout. Reported data on side effects and discontinuation in treatment-resistant depression cohorts, summarized in coverage of ketamine side effects and discontinuation rates, underscores why ongoing monitoring, not a one-time assessment, is part of responsible low-dose ketamine management. Bring your full log rather than a verbal summary; specific dates and numbers are more useful to a prescriber than a general impression that you're "doing better" or "about the same."